Search Within

Neil Mukund Iyengar

  1. "Molecular Imaging and Therapy Service"
Formats
  1. Journal Article (8)
  2. Meeting Abstract (6)
Groups
  1. Breast Medicine Service (14)
  2. Department of Medicine (14)
  3. Molecular Imaging and Therapy Service (14)
  4. Population Sciences Research Program (14)
  5. Radiology, Department of (14)
  6. Solid Tumor Oncology Division (14)

More Groups

People
  1. Maxine Jochelson (11)
  2. Clifford Hudis (9)
  3. Chau Dang (8)
  4. Larry Norton (8)
  5. Shanu Modi (8)
  6. Diana Lake (7)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2021 (1)
  4. 2019 (5)
  5. 2017 (3)
  6. 2016 (1)

More Years

Publications
  1. Journal of Clinical Oncology (3)
  2. Annals of Oncology (2)
  3. Cancer Research (2)
  4. American Journal of Pathology (1)
  5. Biomaterials (1)
  6. Cancer Prevention Research (1)

More Publications

Publishers
  1. American Association for Cancer Research (3)
  2. American Society of Clinical Oncology (3)
  3. Oxford University Press (3)
  4. Amer Assoc Advancement Science (1)
  5. American Medical Association (1)
  6. Elsevier (1)

More Publishers

Results (14)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Biomineralogical signatures of breast microcalcifications
    Journal Article

    Kunitake, J. A. M. R.; Sudilovsky, D.; Johnson, L. M.; Loh, H. C.; Choi, S.; Morris, P. G.; Jochelson, M. S.; Iyengar, N. M.; Morrow, M.; Masic, A.; more...
    Science Advances (2023)

    Fulltext@MSK | Save
  • Increased trunk fat is associated with altered gene expression in breast tissue of normal weight women
    Journal Article

    Cho, B. A.; Iyengar, N. M.; Zhou, X. K.; Mendieta, H.; Winston, L.; Falcone, D. J.; Landa, J.; Morrow, M.; Dannenberg, A. J.
    npj Breast Cancer (2022)

    Fulltext@MSK | Save
  • Effects of adiposity and exercise on breast tissue and systemic metabo-inflammatory factors in women at high risk or diagnosed with breast cancer
    Journal Article

    Iyengar, N. M.; Zhou, X. K.; Mendieta, H.; Giri, D. D.; El-Hely, O.; Winston, L.; Falcone, D. J.; Wang, H.; Meng, L.; Landa, J.; more...
    Cancer Prevention Research (2021)

    Fulltext@MSK | Save
  • Efficacy and safety of gemcitabine with trastuzumab and pertuzumab after prior pertuzumab-based therapy among patients with human epidermal growth factor receptor 2-positive metastatic breast cancer: A phase 2 clinical trial
    Journal Article

    Iyengar, N. M.; Smyth, L. M.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; DeFusco, P.; Fornier, M. N.; Goldfarb, S.; Jhaveri, K.; more...
    JAMA Network Open (2019)

    Fulltext@MSK | Save
  • Improving risk assessment of obesity-associated breast cancer
    Meeting Abstract

    Iyengar, N. M.; Gucalp, A.; Zhou, X. K.; Wang, H.; Giri, D. D.; Williams, S.; Falcone, D. J.; Winston, L.; Landa, J.; Kirstein, L. J.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Hydroxyapatite mineral enhances malignant potential in a tissue-engineered model of ductal carcinoma in situ (DCIS)
    Journal Article

    He, F.; Springer, N. L.; Whitman, M. A.; Pathi, S. P.; Lee, Y.; Mohanan, S.; Marcott, S.; Chiou, A. E.; Blank, B. S.; Iyengar, N.; more...
    Biomaterials (2019)

    Fulltext@MSK | Save
  • Obesity-associated extracellular matrix remodeling promotes a macrophage phenotype similar to tumor-associated macrophages
    Journal Article

    Springer, N. L.; Iyengar, N. M.; Bareja, R.; Verma, A.; Jochelson, M. S.; Giri, D. D.; Zhou, X. K.; Elemento, O.; Dannenberg, A. J.; Fischbach, C.
    American Journal of Pathology (2019)

    Fulltext@MSK | Save
  • Phase II study of weekly paclitaxel with trastuzumab and pertuzumab in patients with human epidermal growth receptor 2 overexpressing metastatic breast cancer: 5-year follow-up
    Journal Article

    Wang, R.; Smyth, L. M.; Iyengar, N.; Chandarlapaty, S.; Modi, S.; Jochelson, M.; Patil, S.; Norton, L.; Hudis, C. A.; Dang, C. T.
    The Oncologist (2019)

    Fulltext@MSK | Save
  • Phase II study of gemcitabine (G), trastuzumab (H), and pertuzumab (P) for HER2-positive metastatic breast cancer (MBC) after prior pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Smyth, L. M.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; DeFusco, P. A.; Dickler, M. N.; Fornier, M. N.; Goldfarb, S. B.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-positive metastatic breast cancer after prior pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Smyth, L. M.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; Defusco, P.; Dickler, M. N.; Fornier, M. N.; Goldfarb, S. B.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save